Faecal Microbiota Transplantation for Recurring Clostridium Difficile Infection in a Patient with Crohn's Disease and Ileorectal Anastomosis

Overview

Journal BMJ Case Rep

Specialty General Medicine

Date 2016 Sep 25

PMID 27664230

Citations 3

Authors

Asser Mathiassen Oppfeldt

Jens F Dahlerup

Lisbet A Christensen

Christian L Hvas

Affiliations

Soon will be listed here.

Abstract

Faecal microbiota transplantation (FMT) is increasingly being used to treat refractory and recurring Clostridium difficile infection (CDI). Although FMT appears to be safe and highly effective in patients with a preserved colon and immunocompetence, its use in patients with inflammatory bowel disease (IBD) who are on immunomodulating therapies is controversial. In particular, patients who have undergone colectomy may have different treatment responses to FMT. In this case report, we describe the successful use of FMT in a female patient aged 19 years with Crohn's disease who underwent ileorectal anastomosis following colectomy. She had recurrent CDIs that were refractory to metronidazole, pulse-tapered vancomycin and fidaxomicin treatments. She underwent 2 FMTs, which were performed via sigmoidoscopy; her mother served as a donor. Follow-up was conducted for 12 months and indicated sustained remission of CDI.

Citing Articles

Implications of Gut Microbiota in Complex Human Diseases.

Yu D, Meng X, de Vos W, Wu H, Fang X, Maiti A Int J Mol Sci. 2021; 22(23).

PMID: 34884466 PMC: 8657718. DOI: 10.3390/ijms222312661.

A Novel and Reliable Rat Model of Autism.

Qi Z, Lyu M, Yang L, Yuan H, Cao Y, Zhai L Front Psychiatry. 2021; 12:549810.

PMID: 33776811 PMC: 7994364. DOI: 10.3389/fpsyt.2021.549810.

Gut dysbacteriosis and intestinal disease: mechanism and treatment.

Meng X, Zhang G, Cao H, Yu D, Fang X, de Vos W J Appl Microbiol. 2020; 129(4):787-805.

PMID: 32277534 PMC: 11027427. DOI: 10.1111/jam.14661.

References

Johnson S . Recurrent Clostridium difficile infection: a review of risk factors, treatments, and outcomes. J Infect. 2009; 58(6):403-10. DOI: 10.1016/j.jinf.2009.03.010. View

Gough E, Shaikh H, Manges A . Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011; 53(10):994-1002. DOI: 10.1093/cid/cir632. View

Borody T, Brandt L, Paramsothy S . Therapeutic faecal microbiota transplantation: current status and future developments. Curr Opin Gastroenterol. 2013; 30(1):97-105. PMC: 3868025. DOI: 10.1097/MOG.0000000000000027. View

Holmer C, Zurbuchen U, Siegmund B, Reichelt U, Buhr H, Ritz J . Clostridium difficile infection of the small bowel--two case reports with a literature survey. Int J Colorectal Dis. 2010; 26(2):245-51. DOI: 10.1007/s00384-010-1001-y. View

Seril D, Shen B . Clostridium difficile infection in the postcolectomy patient. Inflamm Bowel Dis. 2014; 20(12):2450-69. DOI: 10.1097/MIB.0000000000000164. View

van Nood E, Vrieze A, Nieuwdorp M, Fuentes S, Zoetendal E, de Vos W . Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med. 2013; 368(5):407-15. DOI: 10.1056/NEJMoa1205037. View

Furuya-Kanamori L, Stone J, Clark J, McKenzie S, Yakob L, Paterson D . Comorbidities, Exposure to Medications, and the Risk of Community-Acquired Clostridium difficile Infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2015; 36(2):132-41. DOI: 10.1017/ice.2014.39. View

LaVallee C, Laufer B, Pepin J, Mitchell A, Dube S, Labbe A . Fatal Clostridium difficile enteritis caused by the BI/NAP1/027 strain: a case series of ileal C. difficile infections. Clin Microbiol Infect. 2009; 15(12):1093-9. DOI: 10.1111/j.1469-0691.2009.03004.x. View

Manichanh C, Borruel N, Casellas F, Guarner F . The gut microbiota in IBD. Nat Rev Gastroenterol Hepatol. 2012; 9(10):599-608. DOI: 10.1038/nrgastro.2012.152. View

10.

Debast S, Bauer M, Kuijper E . European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect. 2013; 20 Suppl 2:1-26. DOI: 10.1111/1469-0691.12418. View

11.

Dallal R, Harbrecht B, Boujoukas A, Sirio C, Farkas L, Lee K . Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg. 2002; 235(3):363-72. PMC: 1422442. DOI: 10.1097/00000658-200203000-00008. View

12.

Cammarota G, Masucci L, Ianiro G, Bibbo S, Dinoi G, Costamagna G . Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther. 2015; 41(9):835-43. DOI: 10.1111/apt.13144. View

13.

Das R, Feuerstadt P, Brandt L . Glucocorticoids are associated with increased risk of short-term mortality in hospitalized patients with clostridium difficile-associated disease. Am J Gastroenterol. 2010; 105(9):2040-9. DOI: 10.1038/ajg.2010.142. View

14.

Bossuyt P, Verhaegen J, Van Assche G, Rutgeerts P, Vermeire S . Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohns Colitis. 2010; 3(1):4-7. DOI: 10.1016/j.crohns.2008.09.003. View

15.

Garey K, Sethi S, Yadav Y, DuPont H . Meta-analysis to assess risk factors for recurrent Clostridium difficile infection. J Hosp Infect. 2008; 70(4):298-304. DOI: 10.1016/j.jhin.2008.08.012. View

16.

Goodhand J, Alazawi W, Rampton D . Systematic review: Clostridium difficile and inflammatory bowel disease. Aliment Pharmacol Ther. 2011; 33(4):428-41. DOI: 10.1111/j.1365-2036.2010.04548.x. View

17.

Ianiro G, Bibbo S, Scaldaferri F, Gasbarrini A, Cammarota G . Fecal microbiota transplantation in inflammatory bowel disease: beyond the excitement. Medicine (Baltimore). 2014; 93(19):e97. PMC: 4616323. DOI: 10.1097/MD.0000000000000097. View

18.

Louie T, Miller M, Mullane K, Weiss K, Lentnek A, Golan Y . Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med. 2011; 364(5):422-31. DOI: 10.1056/NEJMoa0910812. View

19.

Tsiouris A, Neale J, Reickert C, Times M . Clostridium difficile of the ileum following total abdominal colectomy, with or without proctectomy: who is at risk?. Dis Colon Rectum. 2012; 55(4):424-8. DOI: 10.1097/DCR.0b013e31823f86a2. View

20.

Kelly C, Ihunnah C, Fischer M, Khoruts A, Surawicz C, Afzali A . Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol. 2014; 109(7):1065-71. PMC: 5537742. DOI: 10.1038/ajg.2014.133. View